Fetal Bovine Serum Market Updates 2024: Projected to Surpass USD 1.37 Billion by 2030

Allied Market Research published a report, titled, "Fetal Bovine Serum Market by Application (Biopharmaceuticals, Cell Culture, Human & Animal Vaccine Production, and Others) and End User (Biotechnology & Pharmaceutical Company, Academic Institute, and Research Laboratory): Global Opportunity Analysis and Industry Forecast, 2018-2025." According to the report, the global fetal bovine serum market garnered $695 million in 2017, and is expected to generate $1.03 billion by 2025, registering a CAGR of 5.1 % from 2018 to 2025.

Increase in R&D activities for producing novel biopharmaceuticals along with the expansion of biopharmaceutical industry drives the global fetal bovine serum market growth. Moreover, rise in investments and funding for research activities in developed and developing countries supplement the market growth. However, ethical & scientific issues related to the misuse of biotechnology research practices and scarcity of skilled personnel hinder the growth in the market. Contrarily, untapped potential in emerging geographies would offer new opportunities in the near future.

𝑹𝒆𝒒𝒖𝒆𝒔𝒕 𝑺𝒂𝒎𝒑𝒍𝒆 𝑪𝒐𝒑𝒚 𝒐𝒇 𝑹𝒆𝒑𝒐𝒓𝒕 𝒂𝒕: https://www.alliedmarketresearch.com/request-sample/5261

𝑪𝒆𝒍𝒍 𝒄𝒖𝒍𝒕𝒖𝒓𝒆 𝒔𝒆𝒈𝒎𝒆𝒏𝒕 𝒕𝒐 𝒄𝒐𝒏𝒕𝒊𝒏𝒖𝒆 𝒊𝒕𝒔 𝒍𝒆𝒂𝒅𝒆𝒓𝒔𝒉𝒊𝒑 𝒊𝒏 𝒕𝒆𝒓𝒎𝒔 𝒐𝒇 𝒓𝒆𝒗𝒆𝒏𝒖𝒆 𝒃𝒚 2025

Based on application, the cell culture segment contributed for nearly two-fifths of the total market share, and is estimated to continue its leadership in terms of revenue during the forecast period. This is due to surge in government funding and increase in R&D activities. However, the biopharmaceuticals segment is expected to grow at the highest CAGR of 5.9% from 2018 to 2025, owing to rise in biotechnology research for the development of human & animal vaccines.

𝑩𝒊𝒐𝒕𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒚 𝒂𝒏𝒅 𝒑𝒉𝒂𝒓𝒎𝒂𝒄𝒆𝒖𝒕𝒊𝒄𝒂𝒍 𝒄𝒐𝒎𝒑𝒂𝒏𝒚 𝒔𝒆𝒈𝒎𝒆𝒏𝒕 𝒕𝒐 𝒃𝒆 𝒍𝒖𝒄𝒓𝒂𝒕𝒊𝒗𝒆

Based on end user, the biotechnology and pharmaceutical company segment accounted for nearly half of the total market share in 2017, and is expected to maintain its dominance during the forecast period. Moreover, it is expected to register the highest growth rate, with a CAGR of 5.5% from 2018 to 2025. It is a lucrative segment, owing to increase in research activities related to biotechnology by the key players along with rise in small scale players. The research also analyzes academic institutes and research institutes.

𝑵𝒐𝒓𝒕𝒉 𝑨𝒎𝒆𝒓𝒊𝒄𝒂 𝒕𝒐 𝒊𝒕𝒔 𝒅𝒐𝒎𝒊𝒏𝒂𝒏𝒄𝒆 𝒊𝒏 𝒕𝒆𝒓𝒎𝒔 𝒐𝒇 𝒓𝒆𝒗𝒆𝒏𝒖𝒆 𝒃𝒚 2025

North America accounted for more than two-fifths of the total market share in 2017, and will maintain its dominance in terms of revenue by 2025. This is due to the well-established companies related to biotechnology research and presence of well-equipped research laboratories. On the other hand, Asia-Pacific is estimated to grow at the largest CAGR of 6.3% during the forecast period. This is attributed to penetration of leading biotech companies including Bio-Rad, Thermo Fischer, and others in the region and surge in government initiatives for biotech research.

𝑭𝒐𝒓 𝑷𝒖𝒓𝒄𝒉𝒂𝒔𝒆 𝑬𝒏𝒒𝒖𝒊𝒓𝒚 𝒂𝒕: https://www.alliedmarketresearch.com/purchase-enquiry/5261

𝑲𝒆𝒚 𝑭𝒊𝒏𝒅𝒊𝒏𝒈𝒔 𝑶𝒇 𝑻𝒉𝒆 𝑺𝒕𝒖𝒅𝒚
On the basis of application, the pharmaceutical segment held the largest fetal bovine serum market share in 2020, and is expected to remain dominant throughout the forecast period.
On the basis of end user, the biotechnology & pharmaceutical industries segment held the largest market share in 2020, and is expected to remain dominant throughout the forecast period.
Region wise, North America is held the largest market share in 2020, and is expected to remain dominant throughout the forecast period
Asia-Pacific is anticipated to grow at the highest rate in the fetal bovine serum market during the forecast period, followed by LAMEA

𝑲𝒆𝒚 𝑩𝒆𝒏𝒆𝒇𝒊𝒕𝒔 𝑭𝒐𝒓 𝑺𝒕𝒂𝒌𝒆𝒉𝒐𝒍𝒅𝒆𝒓𝒔
The study provides an in-depth analysis of the fetal bovine serum market size along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers fetal bovine serum market analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and global fetal bovine serum market growth.

𝑲𝒏𝒐𝒘 𝑴𝒐𝒓𝒆- https://www.alliedmarketresearch.com/fetal-bovine-serum-market

𝑶𝒕𝒉𝒆𝒓 𝑻𝒓𝒆𝒏𝒅𝒊𝒏𝒈 𝑹𝒆𝒑𝒐𝒓𝒕𝒔 𝒊𝒏 𝑳𝒊𝒇𝒆 𝑺𝒄𝒊𝒆𝒏𝒄𝒆 𝑫𝒐𝒎𝒂𝒊𝒏
𝑰𝒎𝒎𝒖𝒏𝒐-𝑶𝒏𝒄𝒐𝒍𝒐𝒈𝒚 𝑨𝒔𝒔𝒂𝒚 𝒎𝒂𝒓𝒌𝒆𝒕 https://www.alliedmarketresearch.com/immuno-oncology-assay-market-A06079

𝑺𝒕𝒆𝒓𝒊𝒍𝒊𝒛𝒂𝒕𝒊𝒐𝒏 𝑺𝒆𝒓𝒗𝒊𝒄𝒆𝒔 𝑴𝒂𝒓𝒌𝒆𝒕 https://www.alliedmarketresearch.com/sterilization-services-market-A07513

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.